Estimated delivery in United States, on Thursday 16 Jan 2025
Product Information
Name:
SNDX-5613
Description:
Revumenib, also known as SNDX-5613, is a potent and selective inhibitor of the interaction between menin and the lysine methyltransferase 2A (KMT2A). In recent studies, it has shown promising results in targeting the epigenetic regulator KMT2A, which seems to be involved in certain leukaemia subtypes.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
630.8 g/mol
Formula:
C32H47FN6O4S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 3D-ULD91921 SNDX-5613
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
